P Gibbs

Summary

Affiliation: University of Hull
Country: UK

Publications

  1. ncbi request reprint Textural analysis of contrast-enhanced MR images of the breast
    Peter Gibbs
    Academic Department of Radiology, University of Hull, Hull, United Kingdom
    Magn Reson Med 50:92-8. 2003
  2. doi request reprint Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla
    Peter Gibbs
    Centre for MR Investigations, Division of Cancer, Postgraduate Medical School, University of Hull, Hull, United Kingdom
    Invest Radiol 44:572-6. 2009
  3. ncbi request reprint Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T
    Peter Gibbs
    Center for MR Investigations, Division of Cancer, Postgraduate Medical School, University of Hull, Hull, HU3 2JZ, UK
    Magn Reson Imaging 25:1423-9. 2007
  4. ncbi request reprint Diffusion imaging of the prostate at 3.0 tesla
    Peter Gibbs
    Centre for MR Investigations, Division of Cancer, Postgraduate Medical School, University of Hull, Hull, United Kingdom
    Invest Radiol 41:185-8. 2006
  5. ncbi request reprint Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI
    P Gibbs
    Centre for MR Investigations, Division of Cancer, Postgraduate Medical Institute, University of Hull, Hull HU6 7RX, UK
    Breast 13:115-21. 2004
  6. ncbi request reprint Dynamic contrast-enhanced MRI in the differentiation of breast tumors: user-defined versus semi-automated region-of-interest analysis
    G P Liney
    Academic Department of Radiology, University of Hull, Hull HU6 7RX, United Kingdom
    J Magn Reson Imaging 10:945-9. 1999
  7. ncbi request reprint Bilateral open breast coil and compatible intervention device
    G P Liney
    Hull and East Yorkshire Hospitals NHS Trust, University of Hull, Hull, England
    J Magn Reson Imaging 12:984-90. 2000
  8. ncbi request reprint Assessment of the pore geometry of stereolithographic models by high resolution MRI
    B Issa
    Centre for MRI, Hull Royal Infirmary, UK
    Magn Reson Imaging 16:651-3. 1998
  9. ncbi request reprint Breast lesion analysis of shape technique: semiautomated vs. manual morphological description
    Gary P Liney
    Centre for MR Investigations, University of Hull, Hull, England
    J Magn Reson Imaging 23:493-8. 2006
  10. ncbi request reprint Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T
    Martin D Pickles
    Centre for Magnetic Resonance Investigations, Division of Cancer, Postgraduate Medical School, University of Hull, Hull, UK
    J Magn Reson Imaging 23:130-4. 2006

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Textural analysis of contrast-enhanced MR images of the breast
    Peter Gibbs
    Academic Department of Radiology, University of Hull, Hull, United Kingdom
    Magn Reson Med 50:92-8. 2003
    ..On combining features obtained using textural analysis with lesion size, time to maximum enhancement, and patient age, a diagnostic accuracy of A(z) = 0.92 +/- 0.05 was demonstrated...
  2. doi request reprint Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla
    Peter Gibbs
    Centre for MR Investigations, Division of Cancer, Postgraduate Medical School, University of Hull, Hull, United Kingdom
    Invest Radiol 44:572-6. 2009
    ....
  3. ncbi request reprint Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T
    Peter Gibbs
    Center for MR Investigations, Division of Cancer, Postgraduate Medical School, University of Hull, Hull, HU3 2JZ, UK
    Magn Reson Imaging 25:1423-9. 2007
    ..Fractional anisotropy measurements were found to be less repeatable (between 26% and 71%), and any changes duly recorded in longitudinal studies must therefore be treated with a degree of caution...
  4. ncbi request reprint Diffusion imaging of the prostate at 3.0 tesla
    Peter Gibbs
    Centre for MR Investigations, Division of Cancer, Postgraduate Medical School, University of Hull, Hull, United Kingdom
    Invest Radiol 41:185-8. 2006
    ..We sought to assess the efficacy of diffusion imaging in the differential diagnosis of prostatic carcinoma using a 3.0 T scanner and parallel imaging technology...
  5. ncbi request reprint Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI
    P Gibbs
    Centre for MR Investigations, Division of Cancer, Postgraduate Medical Institute, University of Hull, Hull HU6 7RX, UK
    Breast 13:115-21. 2004
    ..92 +/- 0.03 was achieved. In conclusion, MR imaging of small breast lesions is feasible and the incorporation of quantitative MR derived parameters is beneficial...
  6. ncbi request reprint Dynamic contrast-enhanced MRI in the differentiation of breast tumors: user-defined versus semi-automated region-of-interest analysis
    G P Liney
    Academic Department of Radiology, University of Hull, Hull HU6 7RX, United Kingdom
    J Magn Reson Imaging 10:945-9. 1999
    ..J. Magn. Reson. Imaging 1999; 10:945-949...
  7. ncbi request reprint Bilateral open breast coil and compatible intervention device
    G P Liney
    Hull and East Yorkshire Hospitals NHS Trust, University of Hull, Hull, England
    J Magn Reson Imaging 12:984-90. 2000
    ..Initial phantom tests with the intervention device indicate a potential for this system to be used in the MR-guided localization of breast lesions. J. Magn. Reson. Imaging 2000;12:984-990...
  8. ncbi request reprint Assessment of the pore geometry of stereolithographic models by high resolution MRI
    B Issa
    Centre for MRI, Hull Royal Infirmary, UK
    Magn Reson Imaging 16:651-3. 1998
    ..These parameters were quantified along many angular orientations with a spatial resolution of 0.12 mm, and their distributions clearly revealed the structural anisotropy of the samples...
  9. ncbi request reprint Breast lesion analysis of shape technique: semiautomated vs. manual morphological description
    Gary P Liney
    Centre for MR Investigations, University of Hull, Hull, England
    J Magn Reson Imaging 23:493-8. 2006
    ..To investigate the efficacy of an automated method of shape measurement for improving the discrimination of benign and malignant breast lesions...
  10. ncbi request reprint Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T
    Martin D Pickles
    Centre for Magnetic Resonance Investigations, Division of Cancer, Postgraduate Medical School, University of Hull, Hull, UK
    J Magn Reson Imaging 23:130-4. 2006
    ..0T using a phased-array coil and parallel imaging, and determine the utility of ADC values in differentiating tumor from normal peripheral zone (PZ)...
  11. ncbi request reprint Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer
    Martin D Pickles
    Centre for Magnetic Resonance Investigations, Division of Cancer, Postgraduate Medical School, University of Hull, HU3 2JZ Hull, UK
    Magn Reson Imaging 24:843-7. 2006
    ..057). These results indicate that DWI may provide a suitable biomarker capable of providing an indication of response to treatment prior to tumor size measurements...
  12. doi request reprint Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer
    Bashar Zelhof
    University of Hull, Centrre for MR Investigations, UK
    BJU Int 103:883-8. 2009
    ..To assess the relationship between the apparent diffusion coefficient (ADC) on magnetic resonance imaging (MRI) and cell density (CD) obtained from radical prostatectomy (RP) specimens...
  13. doi request reprint Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue
    Martin Lowry
    Centre for Magnetic Resonance Investigations, University of Hull, Hull, United Kingdom
    Invest Radiol 44:577-84. 2009
    ..We also aspire to assess the impact of tissue heterogeneity on variation in estimated pharmacokinetic parameters...
  14. ncbi request reprint Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy
    Martin D Pickles
    Post Graduate Medical School, Division of Cancer, Centre for Magnetic Resonance Investigations, University of Hull, UK
    Breast Cancer Res Treat 91:1-10. 2005
    ..001). Quantification of dynamic contrast enhancement parameters provides a potential means for differentiating responders from non-responders early during their treatment, thereby allowing a prompt change in treatment if necessary...
  15. ncbi request reprint Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate
    P Gibbs
    Academic Department of Radiology, University of Hull, Hull, UK
    Magn Reson Med 46:1054-8. 2001
    ..040) and central gland (P < 0.001)...
  16. ncbi request reprint Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy
    Ricky A Sharma
    Department of Radiation Oncology and Biology, University of Oxford, Churchill Hospital, Oxford, UK
    J Clin Oncol 25:1099-106. 2007
    ..This treatment has not been tested with the radiosensitizing chemotherapy, oxaliplatin, which appears synergistic in the treatment of CRC when combined with fluorouracil and leucovorin (FOLFOX)...
  17. doi request reprint Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice
    Sumitra Ananda
    J Clin Oncol 26:4516-7; author reply 4517-8. 2008
  18. ncbi request reprint Re: Completion of therapy by Medicare patients with stage III colon cancer
    Peter Gibbs
    J Natl Cancer Inst 98:1582. 2006
  19. ncbi request reprint Pancreatic cancer - current management
    Benjamin N J Thomson
    Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Victoria
    Aust Fam Physician 35:212-7. 2006
    ..Pancreatic cancer remains a common and lethal cancer with a median survival of approximately 6 months...
  20. ncbi request reprint Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience
    Brett G M Hughes
    Medical Oncology Unit, The Canberra Hospital, Canberra, ACT, Australia
    ANZ J Surg 74:951-6. 2004
    ..This protocol has not been widely adopted in Australian centres because of perceived risks of toxicity...
  21. ncbi request reprint A phase II study of neoadjuvant biochemotherapy for stage III melanoma
    Peter Gibbs
    Oncology Department, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Cancer 94:470-6. 2002
    ..Phase II studies of biochemotherapy (combining interleukin-2, interferon-alpha, and multiagent chemotherapy) have reported high response rates and a significant number of durable complete responses in patients with metastatic melanoma...
  22. ncbi request reprint Preoperative chemoradiation for rectal cancer causes prolonged pudendal nerve terminal motor latency
    Jit F Lim
    Department of Colorectal Surgery, Royal Melbourne and Epworth Hospitals, Parkville, Victoria, Australia
    Dis Colon Rectum 49:12-9. 2006
    ..Its impact on pudendal nerve function is unclear. This prospective study evaluated the short-term effect of preoperative combined chemoradiation on anorectal physiologic and pudendal nerve function...
  23. ncbi request reprint How safe is adjuvant chemotherapy and radiotherapy for rectal cancer?
    Michael W T Chao
    Radiation Oncology Victoria, East Melbourne, Department of Medical Oncology, Royal Melbourne Hospital, Parkville, Melbourne, Victoria 3050, Australia
    Asian J Surg 27:147-61. 2004
    ..The aim of this report was to review the morbidity and mortality in all RCTs of adjuvant therapy for rectal cancer...
  24. ncbi request reprint Squamous cell carcinoma arising in a giant condyloma acuminatum (Buschke-Lowenstein tumour)
    Michael W T Chao
    Radiation Oncology Victoria, East Melbourne, Australia
    Asian J Surg 28:238-40. 2005
    ..We describe a case of GCA complicated by malignant transformation, where locoregional control was achieved with combined chemoradiotherapy...
  25. ncbi request reprint Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer
    Michael Chao
    Radiation Oncology Victoria, Royal Milbourne Hospital, Melbourne, Victoria, Australia
    ANZ J Surg 75:286-91. 2005
    ..Here, we report our early experience of preoperative chemotherapy and radiotherapy (CRT) in locally advanced rectal cancer at Radiation Oncology Victoria to determine its efficacy and the rate of sphincter preservation...
  26. ncbi request reprint Phase I and pharmacokinetic evaluation of intravenous hyaluronic acid in combination with doxorubicin or 5-fluorouracil
    Mark A Rosenthal
    Cancer Trials Australia, Department of Clinical Hematology, Medical Oncology and Palliative Care, Royal Melbourne Hospital, Melbourne, Australia
    Chemotherapy 51:132-41. 2005
    ..This study is a preliminary clinical investigation to determine if HA could be safely used in combination with 5-fluorouracil (5-FU) and doxorubicin (DOX)...
  27. ncbi request reprint A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF
    Karl D Lewis
    University of Colorado Cancer Center, Aurora, Colorado, USA
    Cancer Invest 23:303-8. 2005
    ..6 months. Further studies of this novel biochemotherapy regimen are not indicated. Other schedules that incorporate temozolomide and/or GM-CSF and further studies to define the optimal method of delivering IL-2 should be pursued...